Related Experiment Video
Updated: Jan 20, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Utilizing shared internal control arms and historical information in small-sized platform clinical trials
Feiran Jiao1, Wenda Tu2, Sara Jimenez3
1Center for Devices and Radiological Health, U.S. Food and Drug Administration , Silver Spring , MD , USA.
Platform trials and historical borrowing can improve clinical trial efficiency for rare diseases. These methods reduce sample size needs, accelerating drug development by leveraging past trial data.
Area of Science:
- Clinical Trials
- Drug Development
- Biostatistics
Background:
- Patient recruitment for concurrent control arms in pediatric and rare disease clinical trials is challenging.
- Platform trial designs with shared internal control arms can enhance efficiency and speed drug development.
- Historical borrowing, using data from prior trials, offers further improvements in clinical trial efficiency.
Purpose of the Study:
- To discuss the advantages and limitations of platform trial designs.
- To compare various historical data borrowing strategies.
- To propose and evaluate a method for using historical controls in platform trials.
Main Methods:
- Discussion of platform trial designs and historical borrowing strategies.
- Comparison of data pooling, separate analysis, test-then-pool, dynamic pooling, and Bayesian hierarchical modeling (MAP prior).
- Proposal of a procedure for utilizing historical controls in a platform setting, evaluated through simulations.
Main Results:
- Platform trials and historical borrowing offer potential solutions to recruitment challenges.
- Various historical data borrowing methods have different efficiencies and applications.
- Simulations demonstrate the statistical performance and feasibility of the proposed method.
Conclusions:
- Platform trials combined with historical borrowing can significantly improve clinical trial efficiency, especially for rare diseases.
- The proposed method provides a feasible approach for integrating historical controls into platform trials.
- These innovative designs accelerate the drug development process by optimizing resource utilization.
More Related Videos
Related Concept Videos
09:09In Silico Clinical Trials for Cardiovascular Disease
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Statistical Software for Data Analysis and Clinical Trials
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials